These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 660443)

  • 1. [Effect of the extent of pharmaceutical formulation on bioavailability of sulfamethoxazol in human (author's transl)].
    Watanabe Y; Sano M; Motohashi K; Takagishi Y; Doi Y
    Yakugaku Zasshi; 1978 May; 98(5):676-8. PubMed ID: 660443
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of magnesium aluminosilicate on fluidity of pharmaceutical powder (author's transl)].
    Yokoi H; Enomoto S; Takahashi H
    Yakugaku Zasshi; 1978 Apr; 98(4):418-25. PubMed ID: 660409
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the dissolution test of the solid dosage form. I. Correlation of bioavailability and dissolution rate of isonicotinic acid hydrazide tablet (author's transl)].
    Ogata H; Suzuki S; Shibazaki T; Ejima A; Inoue T
    Yakugaku Zasshi; 1978 Jul; 98(7):823-31. PubMed ID: 712546
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug biodisponibility and generic equivalence (author's transl)].
    Jaminet F
    J Pharm Belg; 1977; 32(4):325-46. PubMed ID: 599404
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dissolution behavior and bioavailability of sulfamethoxazole/trimethoprim complex (author's transl)].
    Takagishi Y; Ohsuga K; Ohhama S; Maekawa H
    Yakugaku Zasshi; 1981 Aug; 101(8):740-6. PubMed ID: 7328498
    [No Abstract]   [Full Text] [Related]  

  • 6. [The desintegration mechanism of pharmaceutical tablets with starch (author's transl)].
    Couvreur P; Roland M
    J Pharm Belg; 1976; 31(5):511-32. PubMed ID: 993973
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tablets. XIII. Influence of the nature of certain adjuvants on the qualities of grains and tablets of sulfanilamide. Study of paired diluants: potato starch--monocalcium phosphate, potato starch--dicalcium phosphate].
    Ambandh MY; Millet J; Terrier JL; Puiseux F; Duchene D
    J Pharm Belg; 1974; 29(6):539-59. PubMed ID: 4465438
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tablets. XII. Influence of the nature of certain adjuvants on the qualities of grains and tablets of sulfanilamide. Study of paired diluants: potato starch--tricalcium phosphate].
    Ambandh MY; Paris J; Mangenot O; Puisieux F; Duchene D
    J Pharm Belg; 1974; 29(6):523-38. PubMed ID: 4465437
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of formation of an hydrophilic and continuous network of starch on tablet properties. III. Investigation on mathematical determination of the best starch concentration which garantee the best level of bioavailability from tablets (author's transl)].
    Ringard J; Guyot-Hermann AM
    J Pharm Belg; 1979; 34(4):204-11. PubMed ID: 501514
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of spray drying in pharmacy (author's transl)].
    Kala H; Traue J; Moldenhauer H; Zessin G
    Pharmazie; 1979 Dec; 34(12):779-84. PubMed ID: 397493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-pharmacological studies on the pharmacokinetics of a combination sulfamethoxazol/trimethoprim in normal subjects (author's transl)].
    Donike M; Lücker PW; Simon B
    Arzneimittelforschung; 1977; 27(12):2373-7. PubMed ID: 580054
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of formation of an hydrophilic and continuous network of starch on tablets properties. II. Repercussion on tablets characteristics, depending on conditions of the compression (author's transl)].
    Ringard J; Guyot-Hermann AM
    J Pharm Belg; 1979; 34(3):175-82. PubMed ID: 480129
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relationship between configuration of starch grains in tablet and tablet disintegration (author's transl)].
    Nakai Y; Nakajima S
    Yakugaku Zasshi; 1977 Nov; 97(11):1168-73. PubMed ID: 616814
    [No Abstract]   [Full Text] [Related]  

  • 14. Xylan--a possible filler and disintegrant for tablets.
    Juslin M; Paronen P
    J Pharm Pharmacol; 1984 Apr; 36(4):256-7. PubMed ID: 6144774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Revealing the essence of powders: from the base to the application].
    Sunada H
    Yakugaku Zasshi; 2008 Aug; 128(8):1087-107. PubMed ID: 18670175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmaceutical studies on physical properties of solid form drugs. IV. Behavior of powders in tabletting (author's transl)].
    Kigasawa K; Iimura H; Tanizaki A; Sugahara S; Watabe K; Sugimura H; Shimizu H
    Yakugaku Zasshi; 1979 Jul; 99(7):723-9. PubMed ID: 544790
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 5th Part: Bioavailability of Riboflavin enteric coated tablets (author's transl)].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(4):341-54. PubMed ID: 978382
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug release in vitro from digoxin formulations with high bioavailability (author's transl)].
    Asmussen B; Heinz N
    Arzneimittelforschung; 1980; 30(12):2168-72. PubMed ID: 7194080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorption of phenazopyridine hydrochloride on pharmaceutical adjuvants.
    Meshali MM
    Pharmazie; 1982 Oct; 37(10):718-20. PubMed ID: 7178218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The bioavailability of tetracycline tablets manufactured by pharmaceutical factories in China (author's transl)].
    Li T; Meng JX; Liu DY; Zhu SF; Lu SZ; Gao XY; Shen LL; Yang WS
    Yao Xue Xue Bao; 1981 Nov; 16(11):842-8. PubMed ID: 7342680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.